Last reviewed · How we verify

NCT04825509

Ultrasound-Assessed Diaphragmatic Dysfunction as a Predictor of Weaning Outcome

Completed Last updated 21 July 2022
What this trial tests

trial testing Ultrasound in Weaning Failure in 60 participants. Completed in 1 November 2021.

Timeline
18 April 2021
Primary endpoint
17 October 2021
1 November 2021

Quick facts

Lead sponsorAin Shams University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date18 April 2021
Primary completion17 October 2021
Estimated completion1 November 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, any sex, with Weaning Failure or Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess whether the degree of diaphragm excursion and diaphragm thickening measured by ultrasound during a weaning trial may be used to predict successful weaning from mechanical ventilation in patients with sepsis in intensive care unit

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Weaning Failure

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04825509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing